CYCN Korsana Biosciences, Inc.

Fundamentals / CIK 0001755237 / USD
Other share classes on CIK 0001755237: KRSA

Korsana Biosciences, Inc. reported $2.07M in revenue and a net loss of $58.88M for the fiscal year ended December 31, 2025 (up 3.7% year over year), with a -481.1% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CYCN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

8 fiscal years (2018 to 2025), reported in USD.

$17.43M$8.72M$0-$115.4MFY 2018 Net Income: -$115.3M2018FY 2019 Revenue: $4.51MFY 2019 Net Income: -$123.0M2019FY 2020 Revenue: $2.30MFY 2020 Net Income: -$77.80M2020FY 2021 Revenue: $3.94MFY 2021 Net Income: -$51.65M2021FY 2022 Revenue: $297KFY 2022 Net Income: -$44.08M2022FY 2023 Revenue: $0FY 2023 Net Income: -$5.26M2023FY 2024 Revenue: $2.00MFY 2024 Net Income: -$3.06M2024FY 2025 Revenue: $2.07MFY 2025 Net Income: -$3.53M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $2.07M $2.00M $0 $297K $3.94M $2.30M $4.51M --
Research & Development $959K $286K $1.51M $5.98M $37.64M $56.41M $95.14M $87.72M
Total Operating Expenses $7.05M $5.63M $12.95M $18.84M $59.14M $83.56M $129.5M $115.3M
Operating Income -$4.97M -$3.63M -$12.95M -$18.54M -$55.20M -$81.27M -$125.0M -$115.3M
EBITDA -- -- -$12.95M -$18.48M -$54.72M -$78.97M -$122.3M -$113.7M
Income Before Tax -$3.53M -$3.06M -$5.26M -$44.08M -$51.65M -$122.4M -$122.4M -$115.3M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$3.53M -$3.06M -$5.26M -$44.08M -$51.65M -$77.80M -$123.0M -$115.3M
Basic EPS -$1.11 -$1.21 -$2.25 -$20.28 -$26.40 -$51.20 -$89.80 -$84.20
Diluted EPS -$1.11 -$1.21 -$2.25 -$20.28 -$26.40 -$51.20 -$89.80 -$84.20
Basic Shares Outstanding 3.2M 2.5M 2.3M 2.2M 2.0M 1.5M 1.4M 1.4K
Diluted Shares Outstanding 3.2M 2.5M 2.3M 2.2M 2.0M 1.5M 1.4M 1.4K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- $0 $0 $1.02M $875K $93K $81K $1.81M
Research & Development $42K $0 $730K $938K $20K $56K $36K $56K
Total Operating Expenses $48K $1.77M $3.21M $7.02M $22K $1.76M $1.54M $1.30M
Operating Income -$48K -$1.77M -$3.21M -$4.95M -$22K -$1.67M -$1.46M $502K
Income Tax Expense $0 -- -- -- $0 -- -- --
Net Income -$46.42M -$17.36M -$13.51M $18.42M -$21.72M -$152K -$73K $530K
Basic EPS -$3.19 -$0.41 -$0.76 -- -$39.49 -$0.11 -$0.56 --
Diluted EPS -$3.19 -$0.41 -$0.76 -- -$39.49 -$0.11 -$0.56 --
Basic Shares Outstanding 13.5M 4.3M 4.2M -- 550.1K 3.1M 2.6M --
Diluted Shares Outstanding 13.5M 4.3M 4.2M -- 550.1K 3.1M 2.6M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $154.1M $3.23M $7.57M $13.38M $53.96M $54.40M $94.89M --
Cash & Short-Term Investments $154.1M $3.23M $7.57M $13.38M $53.96M $54.40M $94.89M --
Accounts Receivable, Net $1.00M $556K $0 $96K $100K $0 -- --
Other Current Assets $11K $16K $11K $537K $468K $3.16M $2.86M $12K
Total Current Assets $154.6M $4.22M $8.02M $14.82M $55.46M $58.50M $101.2M $879K
Property, Plant & Equipment, Net $0 $0 $0 $0 $65K $6.87M $11.61M $6.50M
Other Non-Current Assets -- -- $0 $2.04M $2.41M $2.77M $540K $25K
Total Non-Current Assets $0 $5.35M $5.35M $3.26M $3.87M $56.88M $85.28M $6.52M
Total Assets $154.6M $9.57M $13.37M $18.08M $59.33M $115.4M $186.5M $7.40M
Accounts Payable $176K $390K $1.20M $2.97M $1.83M $1.15M $3.23M $2.78M
Short-Term Debt -- -- -- $3.50M $3.50M $3.50M -- --
Other Current Liabilities -- -- -- -- -- -- -- $9.80M
Total Current Liabilities $12.49M $725K $2.09M $7.63M $11.09M $16.95M $18.25M $17.85M
Total Non-Current Liabilities $538K $0 $0 $0 $0 $38.93M $70.50M $0
Total Liabilities $13.03M $725K $2.09M $7.63M $11.09M $55.88M $88.75M $17.85M
Total Debt (incl. Leases) -- -- -- $3.50M $3.50M $45.73M $73.92M --
Common Stock $0 $0 $0 $0 $0 $0 -- --
Retained Earnings -$35.73M -$267.5M -$264.4M -$259.2M -$215.1M -$163.4M -$85.63M --
Accumulated Other Comp. Income -- $0 -$12K -$20K -$23K -$27K -$20K --
Total Stockholders' Equity -$33.97M $66K $11.29M $10.45M $48.25M $59.49M $97.73M -$10.45M
Total Equity $9.09M $8.85M $11.29M $10.45M $48.25M $59.49M $97.73M -$10.45M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $456.2M $1.39M $2.82M $154.1M $4.57M $3.01M $3.64M $3.23M
Cash & Short-Term Investments $456.2M $1.39M $2.82M $154.1M $4.57M $3.01M $3.64M $3.23M
Accounts Receivable, Net -- $0 $0 $1.00M $100K $525K $581K $556K
Other Current Assets -- $11K $11K $11K $11K $27K $21K $16K
Total Current Assets $460.6M $1.51M $3.09M $154.6M $5.07M $4.02M $4.50M $4.22M
Property, Plant & Equipment, Net $367K $66K $66K $0 $0 $0 $0 $0
Total Non-Current Assets $1.44M $5.42M $5.42M $0 $5.35M $5.35M $5.35M $5.35M
Total Assets $462.1M $6.93M $8.51M $154.6M $10.41M $9.37M $9.85M $9.57M
Accounts Payable $1.61M $1.60M $457K $176K $480K $462K $483K $390K
Total Current Liabilities $44.20M $1.84M $1.71M $12.49M $877K $800K $1.07M $725K
Total Non-Current Liabilities $1.36M $0 $0 $538K $0 $0 $0 $0
Total Liabilities $45.56M $1.84M $1.71M $13.03M $877K $800K $1.07M $725K
Total Debt (incl. Leases) $1.27M -- -- -- -- -- -- --
Common Stock $0 $0 $0 $0 $0 $0 $0 $0
Retained Earnings -$113.0M -$276.0M -$274.2M -$35.73M -$270.2M -$269.2M -$268.9M -$267.5M
Accumulated Other Comp. Income -- -- -- -- -- -- -- $0
Total Stockholders' Equity $391.6M -$63.28M -$47.03M -$33.97M -$21.84M -$123K $16K $66K
Total Equity $391.6M $5.09M $6.79M $9.09M $9.54M $8.57M $8.78M $8.85M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$3.53M -$3.06M -$5.26M -$44.08M -$51.65M -$77.80M -$123.0M -$115.3M
Depreciation & Amortization -- -- $0 $65K $472K $2.30M $2.70M $1.53M
Stock-Based Compensation $441K $625K $1.07M $6.25M $9.61M $14.99M $19.63M $12.43M
Change in Receivables -$444K -$556K $96K $4.0K -$100K $0 -- --
Change in Payables $118K -$445K -$1.77M $1.14M $679K -$1.30M -$331K $979K
Operating Cash Flow -$3.31M -$4.33M -$21.25M -$40.61M -$36.52M -$72.49M -$102.2M -$97.50M
Capital Expenditure -- -- -- $0 -$7.0K -$1.52M -$6.89M -$3.44M
Free Cash Flow -- -- -- -$40.61M -$36.52M -$74.01M -$109.1M -$100.9M
Investing Cash Flow -- $0 $10.40M $0 $1.46M $18K -$6.71M -$3.44M
Common Stock Issued $1.38M $0 $5.00M $0 -- -- -- --
Financing Cash Flow $3.32M $0 $5.02M $29K $30.79M $28.09M $211.6M $100.9M
Net Change in Cash $8.0K -$4.34M -$5.81M -$40.58M -$4.27M -$44.39M $102.6M --

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$46.40M -$1.75M -$3.18M $18.42M -$20.20M -$324K -$1.43M $530K
Stock-Based Compensation $17.31M $51K $58K $196K $17K $114K $114K $122K
Change in Receivables -- $0 $1.00M -$900K $425K $56K -$25K -$556K
Change in Payables $343K $1.14M -$51K -$9.73M $9.78M -$21K $93K $86K
Operating Cash Flow -$46.83M -$1.43M -$1.18M $8.48M -$10.33M -$503K -$968K $360K
Capital Expenditure -$231K $0 -$66K -- $0 $0 $0 --
Free Cash Flow -$47.06M -$1.43M -$1.24M -- -$10.33M -$503K -$968K --
Investing Cash Flow -$231K $0 -$66K -- $0 $0 $0 --
Common Stock Issued -- -- -- $0 $0 $0 $1.38M $0
Financing Cash Flow $351.1M $0 $825K -$162.3M $164.3M -$130K $1.38M $0
Net Change in Cash $304.0M -$1.43M -$417K -$153.8M $154.0M -$633K $407K $360K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -239.8% -181.4% -- -6242.4% -1400.2% -3539.4% -2774.3% --
Net Profit Margin -170.1% -152.8% -- -14841.1% -1310.2% -3388.6% -2729.3% --
Return on Equity (ROE) -- -4631.8% -46.6% -421.7% -107.0% -130.8% -125.9% --
Return on Assets (ROA) -2.3% -31.9% -39.4% -243.8% -87.0% -67.4% -66.0% -1557.2%
Current Ratio 12.38x 5.83x 3.85x 1.94x 5.00x 3.45x 5.55x 0.05x
Quick Ratio 12.42x 5.22x 3.63x 1.77x 4.88x 3.21x 5.20x --
Debt to Equity -- -- -- 0.33x 0.07x 0.77x 0.76x --
Revenue Growth (YoY) +3.7% -- -100.0% -92.5% +71.7% -49.1% -- --
5Y Revenue / Share Growth -56.8% -75.9% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -523.8% -494.4% -390.6% -92.8% -172.7% -166.6% -181.4%
Net Profit Margin -- -1798.6% -851.2% -170.1% -750.2% -19.2% -76.3% -152.8%
Return on Equity (ROE) -15.0% -- -- -- -- -- -9925.0% -4631.8%
Return on Assets (ROA) -12.7% -493.1% -199.5% -2.3% -205.6% -4.5% -16.1% -31.9%
Current Ratio 10.42x 0.82x 1.80x 12.38x 5.78x 5.03x 4.21x 5.83x
Quick Ratio 10.32x 0.75x 1.65x 12.42x 5.32x 4.41x 3.96x 5.22x
Debt to Equity 0.00x -- -- -- -- -- -- --
Revenue Growth (YoY) -- -100.0% -100.0% -43.2% +351.0% -- -- --
Operating Income Growth (YoY) -- -- -- -1086.2% -- -- -- --
Net Income Growth (YoY) -- -- -- +3375.5% -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -- +2256.9% -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001755237) · from March 31, 2018 Data through September 30, 2026 · synced Nov 20, 2026, 05:47 UTC · Open in terminal